Cargando…
Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping
The recent identification of compounds that interact with the spliceosome (sudemycins, spliceostatin A, and meayamycin) indicates that these molecules modulate aberrant splicing via SF3B1 inhibition. Through whole transcriptome sequencing, we have demonstrated that treatment of Rh18 cells with sudem...
Autores principales: | Wu, Gang, Fan, Liying, Edmonson, Michael N., Shaw, Timothy, Boggs, Kristy, Easton, John, Rusch, Michael C., Webb, Thomas R., Zhang, Jinghui, Potter, Philip M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049506/ https://www.ncbi.nlm.nih.gov/pubmed/29844105 http://dx.doi.org/10.1261/rna.065383.117 |
Ejemplares similares
-
A spliceosomal twin intron (stwintron) participates in both exon skipping and evolutionary exon loss
por: Kavalecz, Napsugár, et al.
Publicado: (2019) -
ExonSkipDB: functional annotation of exon skipping event in human
por: Kim, Pora, et al.
Publicado: (2020) -
Exon skipping for DMD
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2012) -
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa
por: Bremer, Jeroen, et al.
Publicado: (2019) -
Therapeutic exon skipping for dysferlinopathies?
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2010)